Syncom Formulation (India) Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Syncom Formulation (India) Ltd. on BSE

Load latest

Syncom Formulation (India) Ltd.

08 Jul 2025

17.50

2.04%

Company Update

Syncom Formulations India Ltd-$ - 524470 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, …

BSE India

Certificate for compliance of regulation 74(5) of SEBI DP regulation 2018 for the quarter ended 30th June 2025

pdf

Syncom Formulation (India) Ltd.

25 Jun 2025

17.50

2.04%

SAST

Syncom Formulations India Ltd-$ - 524470 - Closure of Trading Window

BSE India

Pursuant to SEBI (PIT) Reg 2015, the window for trading in the share of the company shall remain close from 1st July, 2025 till completion of 48 hours after the declaration of unaudited standalone and consolidated financial results for the quarther ended on 30th June, 2025.

pdf

Syncom Formulation (India) Ltd.

12 Jun 2025

17.50

2.04%

Company Update

Syncom Formulations India Ltd-$ - 524470 - Announcement Under Regulations 30 (LODR)

BSE India

Disclosure under Reg 30 regarding successful installation of Solar Power plant

pdf

Syncom Formulation (India) Ltd.

21 May 2025

17.50

2.04%

Company Update

Syncom Formulations India Ltd-$ - 524470 - Compliances-Reg.24(A)-Annual Secretarial Compliance

BSE India

Annual Secretarial Compliance Report for the year 2024-25

pdf

Syncom Formulation (India) Ltd.

20 May 2025

17.50

2.04%

Company Update

Syncom Formulations India Ltd-$ - 524470 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Submission of Press clipping of Financial results for the Quarter and year ended 31.03.2025

pdf

Syncom Formulation (India) Ltd.

19 May 2025

17.50

2.04%

Result

Syncom Formulations India Ltd-$ - 524470 - Results For The Quarter And Year Ended 31.03.2025

BSE India

Pursuant to Reg 33 (3 )(d ), the financials results for the year ended 31.03.2025

pdf

Syncom Formulation (India) Ltd.

19 May 2025

17.50

2.04%

Board Meeting

Syncom Formulations India Ltd-$ - 524470 - Board Meeting Outcome for Regulation 33(3)(D) Of SEBI (LODR) …

BSE India

Pursuant to Regulation 33(3)(d) of SEBI (LODR) Regulations, 2015, we are pleased to submit the Standalone & Consolidated Audited Financial Results along with Auditors' Report thereon by Statutory Auditors, Statement of Assets and Liabilities and Cash Flow for the quarter/year ended on 31st March, 2025, in PDF Format, which were approved by the Audit Committee and Board of Directors at their meeting held on Monday, 19th May, 2025.

pdf

Syncom Formulation (India) Ltd.

13 May 2025

17.50

2.04%

Board Meeting

Syncom Formulations India Ltd-$ - 524470 - Board Meeting Intimation for Corporate Announcement U/R 29(1)(A) Of …

BSE India

Syncom Formulations India Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2025 ,inter alia, to consider and approve a) To consider and approve Standalone and Consolidated Audited Financial Results of the Company for the Quarter and year ended 31st March, 2025; b) To take on record the Standalone and Consolidated Audit Report by Auditors for the Audited Financial Results of the Company for the Quarter and year ended 31st March, 2025. c) To consider and approve other matter incidental thereto

pdf

Syncom Formulation (India) Ltd.

13 May 2025

17.50

2.04%

Corp. Note

Syncom Formulations India Ltd-$ - 524470 - Format of the Initial Disclosure to be made by …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanySyncom Formulations India Ltd- 2CIN NO.L24239MH1988PLC047759 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: VAISHALI AGRAWAL Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER EmailId: finance@sfil.in Name of the Chief Financial Officer: Ankit Kedarmal Bankda Designation: CFO EmailId: ankit@sfil.in Date: 13/05/2025 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf

Syncom Formulation (India) Ltd.

17 Apr 2025

17.50

2.04%

Company Update

Syncom Formulations India Ltd-$ - 524470 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, …

BSE India

Certificate for Compliance of Regulation 74(5) of SEBI, DP REG 2018 for the Quarter ended 31.03.2025

pdf

Is Syncom Formulation (India) Ltd. worth buying?

900 Votes:

Buy 83.78%

Sell 8.0%

Hold 8.22%